Westfield Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-654,123
| Closed | -$50.6M | – | 248 |
|
|
2021
Q3 | $50.6M | Buy |
654,123
+35,035
| +6% | +$2.71M | 0.3% | 118 |
|
|
2021
Q2 | $51.7M | Sell |
619,088
-125,697
| -17% | -$10.5M | 0.31% | 122 |
|
|
2021
Q1 | $56.2M | Sell |
744,785
-107,087
| -13% | -$8.09M | 0.35% | 108 |
|
|
2020
Q4 | $74.7M | Buy |
851,872
+214,792
| +34% | +$18.8M | 0.44% | 81 |
|
|
2020
Q3 | $48.5M | Sell |
637,080
-27,977
| -4% | -$2.13M | 0.31% | 104 |
|
|
2020
Q2 | $82M | Sell |
665,057
-173,600
| -21% | -$21.4M | 0.56% | 57 |
|
|
2020
Q1 | $70.9M | Buy |
838,657
+321,207
| +62% | +$27.1M | 0.62% | 50 |
|
|
2019
Q4 | $43.8M | Buy |
+517,450
| New | +$43.8M | 0.31% | 111 |
|
|
2018
Q1 | – | Sell |
-264,630
| Closed | -$23.6M | – | 253 |
|
|
2017
Q4 | $23.6M | Buy |
264,630
+705
| +0.3% | +$62.9K | 0.18% | 177 |
|
|
2017
Q3 | $24.6M | Buy |
263,925
+152,315
| +136% | +$14.2M | 0.19% | 168 |
|
|
2017
Q2 | $10.1M | Sell |
111,610
-152,395
| -58% | -$13.8M | 0.09% | 203 |
|
|
2017
Q1 | $23.2M | Buy |
264,005
+27,535
| +12% | +$2.42M | 0.2% | 153 |
|
|
2016
Q4 | $19.6M | Buy |
236,470
+34,895
| +17% | +$2.89M | 0.17% | 169 |
|
|
2016
Q3 | $18.7M | Buy |
+201,575
| New | +$18.7M | 0.15% | 173 |
|